XL-647 Chemical Properties

Boiling point:

567.9±50.0 °C(Predicted)

Density 

1.356

storage temp. 

Store at -20°C

solubility 

DMF: 10 mg/ml; DMSO: 10 mg/ml; Ethanol: 10 mg/ml

form 

A solid

pka

10.16±0.40(Predicted)

XL-647 Usage And Synthesis

Uses

XL 647 is a potent and selective EGFR phosphorylation inhibitor and may be used in the treatment of patients suffering from lung cancer. Orally available, multi-target tyrosine kinase inhibitor.

Definition

ChEBI: Tesevatinib is a member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, methoxy, and [(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy groups at positions 4, 6 and 7, respectively. It is a multi-target tyrosine kinase inhibitor of EGFR, ErbB2, KDR, Flt4 and EphB4 and exhibits anti-cancer properties. It has a role as an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an epidermal growth factor receptor antagonist. It is a member of quinazolines, an aromatic ether, a member of monofluorobenzenes, a dichlorobenzene, a secondary amino compound, a diether and a tertiary amino compound.

XL-647(781613-23-8)Related Product Information

• AZD 3759
• AG 1478 HYDROCHLORIDE
• OSI-420
• Anlotinib
• EGF816
• Tucatinib
• Neratinib
• Poziotinib (HM781-36B)
• CO-1686
• Dacomitinib (PF299804)
• AZD-9291
• TMC-207
• N-[3-[4-[4-[(Cyclohexylmethylsulfonyl)amino]butyl]piperazin-1-yl]phenyl]acetamide
• RGB-286638 (free base)
• N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide Hcl
• BMS 777607
• Fatostatin A
• Fatostatin A